ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

One method for quantitative evaluation of the state of cells is to track cell metabolism through analysis of the culture medium; however, it’s not possible to gain an accurate understanding of the ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the induction of high-affinity antibodies derived from GCs and produced by ...

Citation Format: Alessandra Perini, Marti Brucoli, Sophie Acton, Luigi Ombrato. Understanding myeloid and lymphoid cell heterogeneity following radiotherapy and its impact on metastasis development in ...

Hematological malignancies may derive from either of the two major blood cell lineages: myeloid and lymphoid cell lines. The myeloid cell line normally produces granulocytes, erythrocytes ...

The proteins that make cell-to-cell cargo transport possible. ScienceDaily . Retrieved February 8, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250115165210.htm ...

1 Department of Targeting Therapy and Immunology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Division of Thoracic Tumor Multimodality Treatment, Cancer Center, ...

Several approaches are currently being developed to combat HCMV infections, including an approach of targeting host cell proteins known as host-directed therapy (Kumar et al., 2020). The ...